Source comparison
Tesamorelin + Ipamorelin Blend: Research Timeline Comparison
Serum GH elevation 30–60 minutes 45–90 minutes post-injection 1mg/kg subcutaneous, single dose Rodent, primate IGF-1 upregulation 7–10 days 14–21 days 1–2mg/kg daily, split dosing Primate Visceral fat reduction (DEXA) 6–8 weeks 10–12 weeks 1mg/kg twice daily R
This comparison does not assign a generated winner or score.
- Serum GH elevation
- 30–60 minutes
- 45–90 minutes post-injection
- 1mg/kg subcutaneous, single dose
- Rodent, primate
- IGF-1 upregulation
- 7–10 days
- 14–21 days
- 1–2mg/kg daily, split dosing
- Primate
- Visceral fat reduction (DEXA)
- 6–8 weeks
- 10–12 weeks
- 1mg/kg twice daily
- Rodent
- Lean tissue gain (DEXA)
- 10–14 weeks
- 1–2mg/kg twice daily
- Insulin sensitivity improvement
- 4–6 weeks
- 8–12 weeks
- Professional Assessment
- GH secretion is immediate, but tissue-level outcomes require 8–12 weeks minimum. Studies measuring endpoints before week 10 risk Type II error. Concluding no effect when the effect timeline hasn't been reached.